Invesco Pharmaceuticals ETF
PJP
95 hedge funds and large institutions have $68.9M invested in Invesco Pharmaceuticals ETF in 2019 Q1 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 34 reducing their positions, and 9 closing their positions.
44% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 9
4% more funds holding
Funds holding: 91 → 95 (+4)
2.41% less ownership
Funds ownership: 17.85% → 15.44% (-2.4%)
19% less capital invested
Capital invested by funds: $85.3M → $68.9M (-$16.4M)
59% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 34
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$2.69M |
| 2 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$532K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$305K |
| 4 |
Creative Planning
Overland Park,
Kansas
|
+$225K |
| 5 |
PAM
Peak Asset Management
Louisville,
Colorado
|
+$220K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$5.93M |
| 2 |
MIH
Madison Investment Holdings
Madison,
Wisconsin
|
-$4.85M |
| 3 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
-$3.16M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.9M |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
-$1.78M |
PJP Hedge Fund Activity: Q1 2019 in Review
95 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Invesco Pharmaceuticals ETF (PJP) for Q1 2019, worth a combined $68.9M — down 19% from $85.3M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new PJP positions and 9 closed out — a net gain of 4 holders — while 14 added to existing stakes and 34 trimmed.
The largest buyer was Bank of America, adding an estimated $2.69M. The largest seller was Morgan Stanley, cutting an estimated $5.93M.
- 95 institutional investors held Invesco Pharmaceuticals ETF (PJP) as of Q1 2019, up from 91 in Q4 2018.
- Funds reported $68.9M of Invesco Pharmaceuticals ETF stock for Q1 2019, down 19% quarter-over-quarter.
- 13 funds opened new Invesco Pharmaceuticals ETF positions in Q1 2019 and 9 closed out, a net change of +4 holders.
- The largest Invesco Pharmaceuticals ETF buyer in Q1 2019 was Bank of America, an estimated $2.69M added.
- The largest Invesco Pharmaceuticals ETF seller in Q1 2019 was Morgan Stanley, an estimated $5.93M sold.
Based on aggregated 13F filings for Q1 2019.